Core GWP Growth (ex-crop & govt health)
11%
+7pp YoY
BAGIC's core business grew 11% vs industry 4%, driven by disciplined underwriting.
BAJAJFINSV
Diversified
24 Oct 2024
Bajajfinsv Ltd — Q2 FY25
Bajaj Finserv reported consolidated revenue growth of 30% YoY to ₹33,703 crore, with PAT up 8% YoY.
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
Bajaj Finserv reported consolidated revenue growth of 30% YoY to ₹33,703 crore, with PAT up 8% YoY. The general insurance business (BAGIC) saw core premium growth of 11% (3x market), though headline GWP fell 20% due to a government health shift to Q3. Combined ratio worsened to 101.4% from 95.3% due to higher natural catastrophe claims. Life insurance (BALIC) grew individual retail new business by 34% YoY, but VNB margins declined 3.8pp to 9.2% due to a mix shift toward ULIPs. Bajaj Finance AUM grew 29% with strong asset quality (GNPA 1.06%). Management highlighted disciplined underwriting and risk management, but flagged near-term headwinds from regulatory changes (surrender value norms) and competitive pressure in credit life. Key risk: further margin compression in life insurance if ULIP dominance persists.
बजाज फिनसर्व का कुल राजस्व पिछले साल की तुलना में 30% बढ़कर ₹33,703 करोड़ हो गया, और मुनाफा 8% बढ़ा। उनकी जनरल इंश्योरेंस कंपनी (BAGIC) का मुख्य प्रीमियम 11% बढ़ा, जो बाजार से तीन गुना ज्यादा है, लेकिन सरकारी स्वास्थ्य योजना के तीसरी तिमाही में शिफ्ट होने से कुल प्रीमियम 20% गिर गया। प्राकृतिक आपदाओं के दावों के कारण कंपनी का खर्च-आय अनुपात बिगड़कर 101.4% हो गया। लाइफ इंश्योरेंस (BALIC) में व्यक्तिगत नए कारोबार में 34% वृद्धि हुई, लेकिन ULIPs की बढ़ती हिस्सेदारी से मुनाफा मार्जिन 9.2% पर आ गया। बजाज फाइनेंस के कुल ऋण में 29% वृद्धि हुई और खराब कर्ज सिर्फ 1.06% रहा। प्रबंधन ने सतर्कता बरतने की बात कही, लेकिन नियामक बदलावों और प्रतिस्पर्धा से चुनौतियों का संकेत दिया। मुख्य जोखिम: लाइफ इंश्योरेंस में ULIPs के बढ़ने से मार्जिन और कम हो सकता है।
Key Numbers
Individual Retail APE Growth
34%
+34% YoY
BALIC's individual retail new business grew 34% YoY, outpacing industry.
VNB Margin
9.2%
-3.8pp YoY
VNB margin fell to 9.2% due to higher ULIP mix; management expects recovery in H2.
Combined Ratio (BAGIC)
101.4%
+6.1pp YoY
Combined ratio worsened to 101.4% due to higher nat cat claims; ex-nat cat it was 99.7%.
What Changed vs Last Quarter
NEW
BALIC VNB margin improvement in H2
Management expects VNB margins to improve in H2 as product mix rebalances away from ULIPs and commission deferrals take effect.
NEW
Bajaj Finserv Direct breakeven in 1-2 quarters
The marketplace business expects to break even on a cash basis within the next couple of quarters.
NEW
Capital deployment of ₹500-600 crore in health & AMC by Mar'26
BFL plans to invest ₹500-600 crore in health tech and asset management over the next 18 months.
NEW
BAGIC core growth to remain above market
Management expects core premium growth to continue outpacing the industry, driven by disciplined underwriting.
DROPPED
BAGIC expects combined ratio to normalize in subsequent quarters
Management indicated that large commercial claims in Q1 are one-offs and not expected to recur, with combined ratio likely improving.
DROPPED
BALIC margins may see a pause in expansion this year due to surrender regulations
New surrender value norms could temporarily impact margin expansion, but medium-term expansion expected through product filings and cost optimization.
DROPPED
BFL expects collection efficiency to improve in H2
Steps taken to strengthen collections and slow rural B2C business should yield results in the second half of FY25.
DROPPED
Bajaj Finserv Health to provide long-term plan in 6-9 months
Post-Vidal acquisition, management will outline a complete long-range plan including breakeven visibility within 6-9 months.
NEW RISK
Allianz exit from JV creates strategic uncertainty
Allianz has informed Bajaj of its decision to exit the joint venture; management provided no further details, creating uncertainty around future ownership and operations.
NEW RISK
VNB margin compression from ULIP mix and regulatory changes
VNB margins fell 3.8pp YoY to 9.2% due to higher ULIP sales; new surrender value norms may further pressure margins.
NEW RISK
Motor TP price hike delay hurting growth
No TP price hike for three years has led to underwriting losses; management has reduced exposure, capping motor growth.
NEW RISK
Retail health profitability under pressure
Medical inflation and hospital fraud are squeezing margins; management is cautious on growth in this segment.
RISK GONE
Elevated loan losses and collection efficiency in BFL
BFL's loan losses and provisions were elevated in Q1 due to muted collection efficiencies and increase in stage 2 assets by INR 864 crore.
RISK GONE
Impact of new surrender regulations on BALIC margins
New IRDA surrender value norms may temporarily slow margin expansion; management was evasive on quantifying the impact.
RISK GONE
Large commercial claims in BAGIC may recur
Though termed one-offs, large property and liability claims caused combined ratio deterioration; similar claims could arise in future.
RISK GONE
Vidal acquisition may lead to customer attrition
Insurance partners of Vidal may withdraw business due to conflict of interest with Bajaj Finserv's insurance arms.
🤫 Topics management stopped discussing
Mentioned in Q3 FY24, Q4 FY24
Acquisition completed in April 2024; integration and utilization of Vidal network to begin next quarter.
Mentioned in Q1 FY24, Q2 FY24
Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.
Mentioned in Q1 FY24, Q2 FY24
Analyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.
Mentioned in Q2 FY24, Q4 FY24
Growth in government health and crop is tender-based and pricing-dependent; management may lose share if pricing becomes unfavorable.
Mentioned in Q3 FY24, Q4 FY24
Regulator may reconsider surrender charge regulations; management declined to comment, indicating potential impact on product profitability.
Management Guidance
BALIC VNB margin improvement in H2
Management expects VNB margins to improve in H2 as product mix rebalances away from ULIPs and commission deferrals take effect.
Management guidance marginsBajaj Finserv Direct breakeven in 1-2 quarters
The marketplace business expects to break even on a cash basis within the next couple of quarters.
Management guidance growthCapital deployment of ₹500-600 crore in health & AMC by Mar'26
BFL plans to invest ₹500-600 crore in health tech and asset management over the next 18 months.
Management guidance capexBAGIC core growth to remain above market
Management expects core premium growth to continue outpacing the industry, driven by disciplined underwriting.
Management guidance growthKey Risks
Allianz exit from JV creates strategic uncertainty
Allianz has informed Bajaj of its decision to exit the joint venture; management provided no further details, creating uncertainty around future ownership and operations.
high · management_commentaryVNB margin compression from ULIP mix and regulatory changes
VNB margins fell 3.8pp YoY to 9.2% due to higher ULIP sales; new surrender value norms may further pressure margins.
medium · analyst_questionMotor TP price hike delay hurting growth
No TP price hike for three years has led to underwriting losses; management has reduced exposure, capping motor growth.
medium · analyst_questionRetail health profitability under pressure
Medical inflation and hospital fraud are squeezing margins; management is cautious on growth in this segment.
medium · management_commentaryNotable Quotes
We have built two solid businesses in life and general insurance business, and we have always held some focus on equity stake, and this will continue to be, Bajaj will continue to be the dominant shareholder in this business, in the times to come.
If you look at our combined ratio, which has always been among the best in the industry.
We are now the third largest company in the life sector in terms of the number of policies we sell in the private sector.
Frequently Asked Questions
What was Bajajfinsv's revenue in Q2 FY25?
Bajajfinsv reported revenue of ₹33,703 Cr in Q2 FY25, representing a +30% change compared to the same quarter last year.
What guidance did Bajajfinsv management give for FY26?
BALIC VNB margin improvement in H2: Management expects VNB margins to improve in H2 as product mix rebalances away from ULIPs and commission deferrals take effect. Bajaj Finserv Direct breakeven in 1-2 quarters: The marketplace business expects to break even on a cash basis within the next couple of quarters. Capital deployment of ₹500-600 crore in health & AMC by Mar'26: BFL plans to invest ₹500-600 crore in health tech and asset management over the next 18 months. BAGIC core growth to remain above market: Management expects core premium growth to continue outpacing the industry, driven by disciplined underwriting.
What are the key risks for Bajajfinsv in FY26?
Key risks include Allianz exit from JV creates strategic uncertainty — Allianz has informed Bajaj of its decision to exit the joint venture; management provided no further details, creating uncertainty around future ownership and operations.; VNB margin compression from ULIP mix and regulatory changes — VNB margins fell 3.8pp YoY to 9.2% due to higher ULIP sales; new surrender value norms may further pressure margins.; Motor TP price hike delay hurting growth — No TP price hike for three years has led to underwriting losses; management has reduced exposure, capping motor growth.; Retail health profitability under pressure — Medical inflation and hospital fraud are squeezing margins; management is cautious on growth in this segment..
Did Bajajfinsv meet its previous quarter's guidance?
Of 2 tracked promises, management 0 met, 0 close, 2 missed.
Where can I read the full Bajajfinsv Q2 FY25 concall transcript?
The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary with filing verification status shown on the financial stats.